Antigen-specific immunotherapy with thyrotropin receptor peptides in Grave's Hyperthyroidism: a Phase I study

dc.contributor.authorVaidya, Bijay
dc.date.accessioned2019-10-24T11:44:29Z
dc.date.available2019-10-24T11:44:29Z
dc.date.issued2019-07
dc.description.abstractGraves' disease is one of the most common autoimmune conditions, but treatment remains imperfect. This study explores the first-in-human use of antigen-specific immunotherapy with a combination of two thyrotropin receptor (TSHR) peptides (termed ATX-GD-59) in Graves' hyperthyroidism.en_US
dc.description.admin-notePublisheden_US
dc.description.noteThis article is freely available via Open Access. Click on the Publisher's URL to access the full-text via the publisher's site.en_US
dc.identifier.citationPearce SHS [et al]. Antigen-specific immunotherapy with thyrotropin receptor peptides in Grave's Hyperthyroidism: a Phase I study.Thyroid. 2019 Jul;29(7):1003-1011en_US
dc.identifier.doi10.1089/thy.2019.0036
dc.identifier.journalThyroiden_US
dc.identifier.pmcidPMC6648194
dc.identifier.pmid31194638
dc.identifier.urihttps://hdl.handle.net/11287/621091
dc.language.isoenen_US
dc.publisherMary Ann Lieberten_US
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31194638/en_US
dc.rightsThis Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en_US
dc.subjectWessex Classification Subject Headings::Endocrinologyen_US
dc.titleAntigen-specific immunotherapy with thyrotropin receptor peptides in Grave's Hyperthyroidism: a Phase I studyen_US
dc.typeJournal Articleen_US
dc.type.versionPublisheden_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Pearce_Thyroid.pdf
Size:
581.47 KB
Format:
Adobe Portable Document Format
Description:
Open Access article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.88 KB
Format:
Item-specific license agreed upon to submission
Description: